Parasite antigen-specific interleukin-10 and antibody responses predict accelerated parasite clearance in Plasmodium falciparum malaria

European Cytokine Network

Volumn 9, Issue 4, 1998, Pages 639-646

  Luty, Adrian J F ^a,b,d   Lell, Bertrand ^a,b,c   Schmidt Ott, Ruprecht ^a,b   Lehman, Leopold G ^a,b   Luckner, Doris ^a,b   Greve, Bernhard ^b   Matousek, Peter ^b,c   Herbich, Klaus ^b,c   Schmid, Daniela ^b   Ulbert, Sebastian ^a   Migot Nabias, Florence ^d   Dubois, Beatrice ^e   Deloron, Philippe ^d,e   Kremsner, Peter G ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ALBERT SCHWEITZER HOSPITAL   (Gabon)

^c UNIVERSITY OF VIENNA   (Austria)

^d CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^e BICHAT HOSPITAL   (France)

Author keywords

Antibody response; Cytokines; Malaria; Parasite clearance

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; PARASITE ANTIGEN; TUMOR NECROSIS FACTOR;

ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION FUNCTION; GABON; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALARIA; MONONUCLEAR CELL; PLASMODIUM FALCIPARUM; TIME;

PLASMODIUM FALCIPARUM;

EID: 0032442755     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Wildling E, Winkler S, Kremsner P G, Brandts C, Jenne L, Wernsdorfer W H. 1993. Malaria epidemiology in the province of Moyen Ogooue, Gabon. Trop. Med. Parasitol. 46: 77.
2. Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, Chantavanich P, Foucault C, Chongsuphajaisiddhi T, Druilhe P. 1991. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 45: 297.
3. Grau G E, Taylor T E, Molyneux M R, Wirima J J, Vassali P, Hommel M, Lambert P H. 1989. Tumour necrosis factor and disease severity in children with falciparum malaria. N. Eng. J. Med. 320: 1586.
4. Mshana R N, Boulandi J, Mshana N M, Mayombo J, Mendome G. 1991. Cytokines in the pathogenesis of malaria: levels of IL-Ibeta, IL-4, IL-6, TNF-alpha and IFN-gamma in plasma of healthy individuals and malaria patients in a holoendemic area. J. Clin. Lab. Immunol. 34: 131.
5. Ringwald P, Peyron F, Vuillez J P, Touze J E, Le Bras J, Deloron P. 1991. Levels of cytokines in plasma during Plasmodium falciparum malaria attacks. J. Clin. Microbiol. 29: 2076.
6. Peyron F, Burdin N, Ringwald P, Vuillez J P, Rousset F, Banchereau J. 1994. High levels of circulating IL-10 in human malaria. Clin. Exp. Immunol. 95: 300.
7. Ferreira A, Schofield L, Enea V, Schellekens H, van der Meide P, Collins W E, Nussenzweig R S, Nussenzweig V. 1986. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science 232: 881.
8. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330: 664.
9. Kumaratilake L M, Ferrante A. 1994. T cell cytokines in malaria: their role in the regulation of neutrophil-and macrophage-mediated killing of Plasmodium falciparum asexual blood forms. (Review) Res. Immunol. 145: 423.
10. Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P. 1995. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med. 182: 409.
11. Kremsner P G, Winkler S, Brandts C, Wildling E, Jenne L, Graninger W, Prada J, Bienzle U, Juillard P, Grau G E. 1995. Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am. J. Trop. Med. Hyg. 53: 532.
12. Mordmuller B G, Metzger W G, Juillard P, Brinkman B M, Verweij C L, Grau G E, Kremsner P G. 1997. Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur. Cytokine Netw. 8: 29.
13. Nüssler A, Drapier J C, Renia L, Pied S, Miltgen F, Gentilini M, Mazier, D. 1991. L-arginine dependent destruction of intrahepatic malaria parasites in response to tumour necrosis factor and/or interleukin-6 stimulation. Eur. J. Immunol. 21: 227.
14. + T cells. J. Exp. Med. 180: 353.
15. Klotz F W, Scheller L F, Seguin M C, Kumar N, Marletta M A, Green S J, Azad A F. 1995. Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites. J. Immunol. 154: 3391.
16. Taylor-Rohinson A W, Looker M. 1998. Sensitivity of malaria parasites to nitric oxide at low oxygen tensions. (Letter) Lancet 351:1630.
17. Druilhe P, Perignon J L. 1997. A hypothesis about the chronicity of malaria infection. Parasitology Today 13: 353.
18. Oeuvray C, Bouharoun-Tayoun H, Gras-Masse H, Bottius E, Kaidoh T, Aikawa M, Filgueira M C, Tartar A, Druilhe P. 1994. Merozoite surface protein-3: a malaria protein inducing antibodies which promote Plasmodium falciparum killing in cooperation with blood monocytes. Blood. 84: 1594.
19. Theisen M, Soe S, Oeuvray C, Thomas A, Vuust J, Danielsen S, Jepsen S, Druilhe P. 1998. The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect. Immun. 66:11.
20. Taylor-Robinson A W. 1995. Regulation of immunity to malaria. Valuable lessons learned from murine models. Parasitology Today 11: 334.
21. Kremsner PG, Winkler S, Wildling E, Prada J, Bienzle U, Graninger W, Nüssler A. 1996. High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 90: 44.
22. Kun J F, Schmidt-Ott R J, Lehman L G, Lell B, Luckner D, Greve B, Matousek P, Kremsner P G. 1998. Merozoite surface antigen-1 and -2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene. Gabon. Trans. R. Soc. Trop. Med. Hyg. 92: 110.
23. De Oliveira G A, Clavijo P, Nussenzweig R S, Nardin E H. 1994. Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B and T cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application. Vaccine 12: 1012.
24. Luty A J, Mayombo J, Lekoulou F, Mshana R. 1994. Immunologic responses to soluble exoantigens of Plasmodium falciparum in Gabonese children exposed to continuous intense infection. Am. J. Trop. Med. Hyg. 51: 720.
25. Kun J F, Mordmuller B, Lell B, Lehman L G, Luckner D, Kremsner P G. 1998. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet. 351: 265.
26. Brasseur P, Agrapart M, Ballet J J, Druilhe P, Warrell M J, Tharavanij S. 1983. Impaired cell-mediated immunity in Plasmodium falciparum-infected patients with high-parasitaemia and cerebral malaria. Clin. Immunol. Immunopathol. 27: 38.
27. Riley E M, Andersson G, Otoo L N, Jepsen S, Greenwood B M. 1988. Cellular immune responses to Plasmodium falcipanim antigens during and after an acute attack of falciparum malaria. Clin. Exp. Immunol. 73: 17.
28. Kremsner P G, Zotter G M, Feldmeier H, Graninger W, Rocha R M, Jansen-Rosseck R, Bienzle U. 1990. Immune response in patients during and after Plasmodium falciparum infection. J. Infect. Dis. 161: 1025.
29. Chougnet C, Tallet S, Ringwald P, Deloron P. 1992. Kinetics of lymphocyte subsets from peripheral blood during a Plasmodium falciparum attack. Clin. Exp. Immunol. 90: 405.
30. Hviid L, Kurtzahls J A, Goka B Q, Oliver-Commey J O, Nkrumah F K, Theander T G. 1997. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria. Infect. Immun. 65: 4090.
31. Kremsner P G, Winkler S, Brandts C, Graninger W, Bienzle U. 1993. Curing of chloroquine-resistant malaria with clindamycin. Am. J. Trop. Med. Hyg. 49: 650.
32. Guerin-Marchand C, Druilhe P, Galey A, Londono A, Patarapotikul R, Beaudoin C, Dubeaux C, Tartar A, Mercereau-Puijalon O, Langsley G. 1987. A liver stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 329: 164.
33. Fidock D A, Gras-Masse H, Lepers J P, Brahimi K, Benmohamed L, Mellouk S, Guerin-Marchand C, Londono A, Raharimalala L, Meis J F, Langsley G, Roussilhon C, Tartar A, Druilhe P. 1994. Plasmodium falciparum Liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J. Immunol. 153: 190.
34. Hill A V, Elvin J, Willis A C, Aidoo M, Allsopp C E, Gotch F M, Gao X M, Takiguchi M, Greenwood B M, Townsend A R, McMichael A J, Whittle H C. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature. 360: 434.
35. Erard F, LcGros G. 1994. Th2-like CD8 T cells: their role in protection against infectious diseases. Parasitology Today 10: 313.
36. De Waal Malefyt R, Abrams J, Bennot B, Figdor C G, de Vries J E. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209.
37. Riley E M, Allen S J, Wheeler J G, Blackman M J, Bennett S, Takacs B, Schönfeld H J, Holder A A, Greenwood B M. 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 14: 321.
38. Tolle R, Früh K, Doumbo O, Koita O, N'Diaye M, Fischer A, Dietz K, Bujard H. 1993. A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections. Infect. Immun. 61: 40.
39. al-Yaman F, Genton B, Anders R F, Falk M, Triglia T, Lewis D, Hii J, Beck H P, Alpers M P. 1994. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am. J. Trop. Med. Hyg. 51: 593.
40. al-Yaman F, Genton B, Kramer K J, Chang S P, Hui G S, Baisor M, Alpers M P. 1996. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. Am. J. Trop. Med. Hyg. 54: 443.
41. Egan A F, Morris J, Barnish G, Allen S, Greenwood B M, Kaslow D C, Holder A A, Riley E M. 1996. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Inject. Dis. 173:765.
42. Taylor R R, Allen S J, Greenwood B M, Riley E M. 1998. IgG3 antibodies to Plasmodium falciparum merozoite surface protein-2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am. J. Trop. Med. Hyg. 58: 406.
43. Ferrante A, Rzepczyk C M. 1997. Atypical IgG subclass antibody responses to Plasmodium falciparum asexual stage antigens. Parasitology Today 13: 145.
44. +) B cells to secrete IgG1 and IgG3. J. Exp. Med. 179: 757.
45. Fujiedu S, Saxon A, Zhang K. 1996. Direct evidence that γ1 and y3 switching in human B cells is interleukin-10 dependent. Mol. Immunol. 33: 1335.
46. Chizzolini C, Grau G E, Geinoz A, Schrijvers D. 1990. T lymphocyte interferon-gamma production induced by Plasmodium falciparum antigen is high in recently infected nonimmune and low in immune subjects. Clin. Exp. Immunol. 79:95.
47. Binh V Q, Luty A J F, Kremsner P G. 1997. Differential effects of human serum and cells on the growth of Plasmodium falcipam adapted to serum-free in vitro culture conditions. Am. J. Trop. Med. Hyg. 57: 594.